Emmanuel Okwelogu

University of Manchester

How biomarkers can identify cancer in its early stages

In this video, Emmanuel Okwelogu, Ph.D. researcher at the University of Manchester, discusses his research using 2D nanomaterials for the discovery of novel biomarkers that can aid the early detection of certain cancers. Okwelogu also highlights the importance of biosafety in this work and reveals how biosafety cabinets are critical to preventing downstream experimental failures.



LIKE 2


Emmanuel Okwelogu
Cell Biology Cancer Research

Emmanuel Okwelogu

Biography

Emmanuel Okwelogu, Ph.D. researcher at the University of Manchester More
Follow Emmanuel

Emmanuel Okwelogu

University of Manchester

Emmanuel completed his 5-year Bachelor of Pharmacy degree in 2015 at the University of Lagos, Nigeria. After the completion of his professional clinical pharmacy training, in 2019 Emmanuel obtained an MSc in Genes, Drugs and Stem Cells - Novel therapies at Imperial College, London. His collaborative research project between the National Heart and Lung Institute and Dept. of Bioengineering was focused on the development of biodegradable nanoparticles for gene therapy delivery to lungs epithelial cells. In 2020, Emmanuel joined the Nanomedicine lab after being offered a 4 year CDT Ph.D. studentship in Graphene NOWNANO at the University of Manchester. His current research is focused on developing 2D nano-corona technology for the analysis of the cancer cell secretome and biomarker discovery.